Thoracic endografting is rapidly approaching trim time.

Area of Science:

• Vascular Surgery
• Medical Devices
• Interventional Cardiology

Background:

• Thoracic aortic endografting is an emerging endovascular technique for treating thoracic aortic lesions.
• Traditional open repair involves significant risks and complications, including sternotomy, prolonged recovery, and potential organ damage.

Purpose of the Study:

• To evaluate the efficacy and safety of thoracic aortic endografting as an alternative to open surgical repair.
• To highlight the benefits of endovascular intervention in reducing perioperative complications and hospital stays.

Main Methods:

• Review of current literature and outcomes from centers of excellence performing thoracic aortic endografting.
• Comparison of endografting with traditional open surgical repair, considering patient anatomy and pathology.

Main Results:

• Endovascular intervention avoids major open-chest surgery, reducing blood loss, need for ventilation, and intensive care.
• Studies indicate minimized risks of paraplegia, renal failure, and cardiopulmonary complications compared to open repair.
• Excellent outcomes are reported for thoracic aortic endografting in patients with suitable anatomy and pathology.

Conclusions:

• Thoracic aortic endografting is a valuable alternative to open repair, offering reduced morbidity and shorter recovery.
• As devices and experience grow, endografting is expected to become the preferred treatment for thoracic aortic diseases.
• Further research is needed, but current evidence suggests favorable results for carefully selected patients.